OOIR: Observatory of International Research

Papers

(The H4-Index of Annual Review of Medicine is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Carbon Monoxide Poisoning: From Microbes to Therapeutics	550
Clinical Phenotypes of Cystic Fibrosis Carriers	415
Normal Gut Microbiomes in Diverse Populations: Clinical Implications	273
COVID-19 Vaccines: Adenoviral Vectors	264
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines	203
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic Complication	160
Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells	149
Gender-Affirming Care of Transgender and Gender-Diverse Youth: Current Concepts	145
Treatments for COVID-19	127
New Biological Therapies for Multiple Myeloma	127
New Therapeutic Approaches to Large-Vessel Vasculitis	123
Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia	121
Care Models for Cancer Survivors	109
Cystic Fibrosis Modulator Therapies	108
Club Cell Secretory Protein in Lung Disease: Emerging Concepts and Potential Therapeutics	98
Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss	88
Health Effects of Wildfire Smoke Exposure	87
Precision Approaches to Chronic Obstructive Pulmonary Disease Management	85
Xenotransplantation: Promises and Perils	84
Advances in Therapy for Refractory Epilepsy	82
Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection	82
Exercise in Octogenarians: How Much Is Too Little?	81
Spontaneous Coronary Artery Dissection: New Insights into This Not-So-Rare Condition	78
Application and Expectations for Immune Checkpoint Blockade of LAG3 and TIGIT	71
COVID-19 and Kidney Disease	65

MELD 3.0 in Advanced Chronic Liver Disease	65
Clinical Perspectives on IgG4-Related Disease and Its Classification	62
Phage Therapy for Antibiotic-Resistant Bacterial Infections	59
Next-Generation Noninvasive Colorectal Cancer Screening	58
Myocardial Infarction with Nonobstructive Coronary Arteries	54
Sleep Health Disparities	54
Genetics of Dilated Cardiomyopathy	50
The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic Therapies	47
Kawasaki Disease Vasculitis: From Diagnosis to New Concepts in Pathophysiology and Therapeutic Approaches	47
	46
Update on the Porphyrias	45
RASopathies in Cardiac Disease	45
The Hospitalist Movement 25 Years Later	43
Update in Adult Transgender Medicine	42
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment	42
SGLT2 Inhibitors: The Sweet Success for Kidneys	40